Scopus Biopharma Current Assets

Scopus Biopharma's current assets stands at $500K as of June 2023. That compares with $1.7M in the prior-year period — down 70.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Scopus Biopharma reported $500K in current assets versus $1.7M a year earlier — a 70.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $1.7M in the prior-year period — down 70.3% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Scopus Biopharma's current assets evolved across reporting periods, while the comparison chart places SCPS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current assets is commonly used to spot outliers. Scopus Biopharma's reading of $500K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.